Related Experiment Videos

Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: comparison to previous three

M Yücesoy1, N Yuluğ, S Kocagöz

  • 1Dokuz Eylül University Faculty of Medicine, Department of Microbiology and Clinical Microbiology, Inciralti, Izmir, Turkey. mineyucesoy@hotmail.com

Insights

Antibiotic resistance in intensive care units (ICUs) showed mixed trends. While resistance to some drugs increased, susceptibility to imipenem and cefepime remained stable in 1998, possibly due to surveillance programs.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Gram-negative bacteria are a significant cause of hospital-acquired infections, particularly in intensive care units (ICUs).
  • Monitoring antibiotic resistance patterns is crucial for effective treatment strategies and infection control.

Purpose of the Study:

  • To evaluate and compare antibiotic resistance rates of gram-negative bacteria from Turkish ICUs in 1998 with data from the preceding three years.
  • To identify trends in antimicrobial susceptibility and resistance.

Main Methods:

  • A multicenter study involving 16 Turkish hospitals collected 1,404 gram-negative bacterial isolates from 1,060 ICU patients.
  • Antibiotic susceptibility testing was performed using Etest for various agents including imipenem, ciprofloxacin, and cefepime.
  • Isolates were primarily from urinary and respiratory tracts.

Main Results:

  • Pseudomonas spp. (29.7%), Escherichia coli, Acinetobacter, and Klebsiella spp. were the most common gram-negative isolates.
  • Imipenem (73.4% susceptible) was the most active agent, followed by ciprofloxacin (60.6%) and cefoperazone-sulbactam (58.7%).
  • While overall susceptibility declined in 1996 and increased in 1997, 1998 showed stable susceptibility to imipenem and cefepime, a tendency for increased amikacin resistance, and favorable increases for other antibacterials.

Conclusions:

  • Antibiotic resistance patterns in Turkish ICUs exhibited dynamic changes over a four-year period.
  • The implementation of a surveillance program and enhanced understanding of resistance may have contributed to observed trends.
  • Continued monitoring is essential to guide antimicrobial therapy and combat resistance.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...